Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 851Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 9Sabril

PharmaCompass

01

Brand Name : Sabril

Vigabatrin

arrow
American Pharma Summit
Not Confirmed

Brand Name : Sabril

arrow
American Pharma Summit
Not Confirmed

Vigabatrin

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2020 Revenue in Millions : 126

2019 Revenue in Millions : 138

Growth (%) : -8

blank

02

Brand Name : Sabril

Vigabatrin

arrow
American Pharma Summit
Not Confirmed

Brand Name : Sabril

arrow
American Pharma Summit
Not Confirmed

Vigabatrin

Main Therapeutic Indication : Neurology

Currency : USD

2021 Revenue in Millions : 100

2020 Revenue in Millions : 124

Growth (%) : -15

blank

03

Brand Name : Sabril

Vigabatrin

arrow
American Pharma Summit
Not Confirmed

Brand Name : Sabril

arrow
American Pharma Summit
Not Confirmed

Vigabatrin

Main Therapeutic Indication : Neurology

Currency : USD

2022 Revenue in Millions : 92

2021 Revenue in Millions : 100

Growth (%) : -9

blank

04

Brand Name : Sabril

Vigabatrin

arrow
American Pharma Summit
Not Confirmed

Brand Name : Sabril

arrow
American Pharma Summit
Not Confirmed

Vigabatrin

Main Therapeutic Indication : Neurology

Currency : USD

2023 Revenue in Millions : 48

2022 Revenue in Millions : 92

Growth (%) : -47

blank

05

Brand Name : Sabril

Vigabatrin

arrow
American Pharma Summit
Not Confirmed

Brand Name : Sabril

arrow
American Pharma Summit
Not Confirmed

Vigabatrin

Main Therapeutic Indication : Neuroscience and Mental Health

Currency : USD

2015 Revenue in Millions : 107

2014 Revenue in Millions : 148

Growth (%) : 38%

blank

06

Brand Name : Sabril

Vigabatrin

arrow
American Pharma Summit
Not Confirmed

Brand Name : Sabril

arrow
American Pharma Summit
Not Confirmed

Vigabatrin

Main Therapeutic Indication : Neuroscience/Mental Health

Currency : USD

2014 Revenue in Millions : 35%

2013 Revenue in Millions :

Growth (%) :

blank

07

Brand Name : Sabril

Vigabatrin

arrow
American Pharma Summit
Not Confirmed

Brand Name : Sabril

arrow
American Pharma Summit
Not Confirmed

Vigabatrin

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2017 Revenue in Millions : 257

2016 Revenue in Millions : 228

Growth (%) : 12

blank

08

Brand Name : Sabril

Vigabatrin

arrow
American Pharma Summit
Not Confirmed

Brand Name : Sabril

arrow
American Pharma Summit
Not Confirmed

Vigabatrin

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2018 Revenue in Millions : 201

2017 Revenue in Millions : 226

Growth (%) : -11%

blank

09

Brand Name : Sabril

Vigabatrin

arrow
American Pharma Summit
Not Confirmed

Brand Name : Sabril

arrow
American Pharma Summit
Not Confirmed

Vigabatrin

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2019 Revenue in Millions : 127

2018 Revenue in Millions : 201

Growth (%) : -37

blank